Cargando…
Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer
Chemotherapy is still one of the principal treatments for gastric cancer, but the clinical application of 5-FU is limited by drug resistance. Here, we demonstrate that ferroptosis triggered by STAT3 inhibition may provide a novel opportunity to explore a new effective therapeutic strategy for gastri...
Autores principales: | Ouyang, Shumin, Li, Huaxuan, Lou, Linlin, Huang, Qiuyao, Zhang, Zhenhua, Mo, Jianshan, Li, Min, Lu, Jiaye, Zhu, Kai, Chu, Yunjie, Ding, Wen, Zhu, Jianzheng, Lin, Ziyou, Zhong, Lin, Wang, Junjian, Yue, Peibin, Turkson, James, Liu, Peiqing, Wang, Yuanxiang, Zhang, Xiaolei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108091/ https://www.ncbi.nlm.nih.gov/pubmed/35483272 http://dx.doi.org/10.1016/j.redox.2022.102317 |
Ejemplares similares
-
Targeting STAT3-VISTA axis to suppress tumor aggression and burden in acute myeloid leukemia
por: Mo, Jianshan, et al.
Publicado: (2023) -
A novel STAT3 inhibitor W2014-S regresses human non-small cell lung cancer xenografts and sensitizes EGFR-TKI acquired resistance
por: Zheng, Qiyao, et al.
Publicado: (2021) -
The Double-Edged Sword of SIRT3 in Cancer and Its Therapeutic Applications
por: Ouyang, Shumin, et al.
Publicado: (2022) -
Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells
por: Yue, Peibin, et al.
Publicado: (2011) -
Identification of Purine-Scaffold Small-Molecule Inhibitors of Stat3 Activation by QSAR Studies
por: Shahani, Vijay M., et al.
Publicado: (2010)